Quantitative phosphoproteomic analysis of neuronal intermediate filament proteins (NF‐M/H) in Alzheimer's disease by iTRAQ

Abstract

Aberrant hyperphosphorylation of neuronal cytoskeletal proteins is one of the major pathological hallmarks of neurodegenerative disorders such as Alzheimer disease (AD), amyotrophic lateral sclerosis (ALS), and Parkinson's disease (PD). Human NF‐M/H display a large number of multiple KSP repeats in the carboxy‐terminal tail domain, which are phosphorylation sites of proline‐directed serine/threonine (pSer/Thr‐Pro, KS/T‐P) kinases. The phosphorylation sites of NF‐M/H have not been characterized in AD brain. Here, we use quantitative phosphoproteomic methodology, isobaric tag for relative and absolute quantitation (iTRAQ), for the characterization of NF‐M/H phosphorylation sites in AD brain. We identified 13 hyperphosphorylated sites of NF‐M;9 Lys‐Ser‐Pro (KSP) sites;2 variant motifs, Glu‐Ser‐Pro (ESP) Ser‐736 and Leu‐Ser‐Pro (LSP) Ser‐837;and 2 non‐S/T‐P motifs, Ser‐783 and Ser‐788. All the Ser/Thr residues are phosphorylated at significantly greater abundance in AD brain compared with control brain. Ten hyperphosphorylated KSP sites have been identified on the C‐terminal tail domain of NF‐H, with greater abundance of phosphorylation in AD brain compared with control brain. Our data provide the direct evidence that NF‐M/H are hyperphosphorylated in AD compared with control brain and suggest the role of both proline‐directed and non‐proline‐directed protein kinases in AD. This study represents the first comprehensive iTRAQ analyses and quantification of phosphorylation sites of human NF‐M and NF‐H from AD brain and suggests that aberrant hyperphosphorylation of neuronal intermediate filament proteins is involved in AD.—Rudrabhatla, P., Grant, P., Jaffe, H., Strong, M. J., Pant, H. C. Quantitative phosphoproteomic analysis of neuronal intermediate filament proteins (NF‐M/H) in Alzheimer's disease by iTRAQ. FASEB J . 24, 4396–4407 (2010). www.fasebj.org